Hematology
Credibility 80
Knowledge Translation of Pharmacogenomics for Pain Management in Patients With Sickle Cell Disease-A Qualitative Study.
July 1, 2026 · Journal of pediatric hematology/oncology
Key takeaway
Our community members with sickle cell disease deserve better pain management. This study found that many doctors lack knowledge about using genetics to personalize pain medicine, which could lead to better pain control and fewer side effects. We need to better educate providers and update electronic health records so doctors can use this information to improve care.
Why this matters for our communities
Research in hematology helps close long-standing gaps in how Black and African American families are studied, diagnosed, and cared for. Use findings like this one to start informed conversations with your care team — not as a substitute for personal medical advice.
More in Hematology
October 13, 2026Arginine Therapy for Sickle Cell Disease Acute Pain Episodes: The STArT Randomized Clinical Trial.Read August 24, 2026Experiences of family building counseling and perceptions of reproductive technology among adults with sickle cell disease.Read August 20, 2026Risk of infertility among women with sickle cell disease.Read